Summary by Moomoo AI
Senti Biosciences, Inc. (Senti) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on July 10, 2024. The meeting will address several key proposals, including the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and amendments to the company's Second Amended and Restated Certificate of Incorporation. These amendments involve the inclusion of an officer exculpation provision and the authorization of a reverse stock split of the company's common stock at a ratio determined by the board of directors. Additionally, the meeting will consider the adjournment of the Annual Meeting to solicit additional proxies if necessary. The board has fixed May 13, 2024, as the record date for stockholder entitlement to notice and voting rights at the meeting. Senti Biosciences is utilizing the SEC's 'Notice and Access' rule to furnish proxy materials online, reducing environmental impact and mailing costs. Stockholders will be able to vote electronically and submit questions during the virtual meeting.